デフォルト表紙
市場調査レポート
商品コード
1711271

テレファーマシーの世界市場レポート 2025年

Telepharmacy Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.28円
テレファーマシーの世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

テレファーマシーの市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率(CAGR)16.4%で261億8,000万米ドルに成長します。予測期間の成長は、仮想ケアパートナーシップの増加、クラウドベースのソリューションの採用拡大、慢性疾患管理の強化、統合ケアモデルの需要、在宅医療サービスの成長に起因しています。予測期間における主要動向には、ウェアラブルデバイスとの技術統合、モバイルヘルス(mヘルス)アプリケーションの開発、通信技術の進歩、遠隔医療技術の進歩、電子カルテ(EHR)との統合などがあります。

慢性疾患管理に対する需要の高まりは、テレファーマシー市場の成長を促進すると予想されます。慢性疾患管理には、糖尿病、高血圧、心臓病、喘息、関節炎などの長期的な病状を持つ個人の継続的な治療、モニタリング、サポートが含まれます。このような需要の高まりは、慢性疾患の有病率の増加と、患者の転帰を向上させるための長期的で個別化されたケアの必要性によるものです。テレファーマシーは、患者の服薬アドヒアランスとケアへのアクセスを向上させる遠隔服薬カウンセリングとモニタリングを提供することで、慢性疾患管理をサポートします。例えば、米国心臓病学会が2022年8月に発表した報告書では、米国における4つの主要な心血管危険因子すべてが2025~2060年にかけて増加すると予測されています。糖尿病が最も増加し、39.3%増の5,500万人、次いで脂質異常症(27.6%増の1億2,600万人)、高血圧(25.1%増の1億6,200万人)、肥満(18.3%増の1億2,600万人)が続くと予想されています。このように、慢性疾患管理に対するニーズの高まりが、テレファーマシー市場の成長を後押ししています。

テレファーマシー市場の主要企業は、患者の医薬品へのアクセスを改善するために、遠隔医療プラットフォームなどの革新的なソリューションの創出に注力しています。遠隔医療プラットフォームとは、ビデオ会議、メッセージング、安全なデータ共有などのコミュニケーションツールを用いて、医療サービスを遠隔地から提供することを可能にするデジタル技術です。これにより、医療プロバイダと患者の間で、対面での診察を必要としないバーチャルな診察、モニタリング、診断、治療が可能になります。例えば、2024年1月、米国の製薬会社Eli Lillyは、特定の医薬品を消費者に直接販売することを目的とした遠隔医療プラットフォームLillyDirectを立ち上げました。この革新的なプラットフォームにより、患者は肥満、偏頭痛、糖尿病などの症状に対して、従来型医療経路や通常の医師から薬局へのプロセスをバイパスして配合を受けることができます。主要特徴として、処方箋への直接アクセスと宅配があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場-金利、インフレ、地政学、新型コロナウイルス感染症、景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のテレファーマシーPESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のテレファーマシー市場:成長率分析
  • 世界のテレファーマシー市場の実績:規模と成長、2019~2024年
  • 世界のテレファーマシー市場の予測:規模と成長、2024~2029年、2034年
  • 世界のテレファーマシー総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のテレファーマシー市場:タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 入院患者
  • リモート分注
  • 静脈内混合液
  • 患者カウンセリング
  • 薬剤療法モニタリング
  • 処方薬の再配合承認
  • 世界のテレファーマシー市場:コンポーネント別、実績と予測、2019~2024年、2024~2029年、2034年
  • ハードウェア
  • ソフトウェア
  • 世界のテレファーマシー市場:提供方法別、実績と予測、2019~2024年、2024~2029年、2034年
  • オンプレミス
  • ウェブベース
  • クラウドベース
  • 世界のテレファーマシー市場:用途別、実績と予測、2019~2024年、2024~2029年、2034年
  • 病院
  • 小規模薬局
  • 高齢者ホーム
  • 刑務所
  • 軍事基地
  • 軍艦
  • 世界のテレファーマシー市場、入院患者のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 病院テレファーマシー
  • 専門薬局
  • 世界のテレファーマシー市場、リモート分注のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 自動販売機
  • 遠隔患者モニタリング
  • 世界のテレファーマシー市場、静脈内混合液のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 完全静脈栄養
  • 調剤薬
  • 世界のテレファーマシー市場、患者カウンセリングのサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • ビデオ相談
  • チャットサポート
  • 世界のテレファーマシー市場、薬剤療法モニタリングのサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 遵守モニタリング
  • 副作用管理
  • 世界のテレファーマシー市場、処方薬の再配合承認のサブセグメンテーション、タイプ別、実績と予測、2019~2024年、2024~2029年、2034年
  • 自動補充
  • 患者リクエストシステム

第7章 地域別・国別分析

  • 世界のテレファーマシー市場:地域別、実績と予測、2019~2024年、2024~2029年、2034年
  • 世界のテレファーマシー市場:国別、実績と予測、2019~2024年、2024~2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • テレファーマシー市場:競合情勢
  • テレファーマシー市場:企業プロファイル
    • Cardinal Health Inc.
    • Dartmouth-Hitchcock Medical Center
    • Comprehensive Pharmacy Services Inc.
    • Tabula Rasa HealthCare
    • Alto Pharmacy

第31章 その他の大手企業と革新的企業

  • CarepathRx
  • Truepill
  • Carepoint Pharmacy
  • Pipeline Health Holdings
  • Nurx
  • Advanced Rx Management
  • Mosaic Wellness
  • MedTel Services
  • Medication Review Inc.
  • Phlo
  • Locke Bio
  • PharmD Live
  • North West TelePharmacy Solutions
  • One Touch Telehealth
  • Heyva Health

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、戦略

  • テレファーマシー市場、2029年:新たな機会を提供する国
  • テレファーマシー市場、2029年:新たな機会を提供するセグメント
  • テレファーマシー市場、2029年:成長戦略
    • 市場動向による戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r32296

Telepharmacy involves delivering pharmaceutical care using telecommunication technology, which allows pharmacists to provide consultations, manage medications, and handle prescriptions from a distance. This method increases access to pharmacy services, particularly in remote or underserved regions. By offering prompt support and medication guidance, it enhances patient care.

Telepharmacy can be categorized into several types such as inpatient, remote dispensing, intravenous admixture, patient counseling, drug therapy monitoring, and refill authorization for prescriptions. Inpatient telepharmacy specifically refers to pharmacists delivering services to patients in hospitals or healthcare facilities from a remote location, utilizing technology to review medication orders, verify dosing accuracy, and monitor patient outcomes. The system comprises both hardware and software and can be delivered via on-premise, web-based, or cloud-based methods. Its applications span hospitals, small pharmacies, nursing homes, prisons, military bases, and warships.

The telepharmacy market research report is one of a series of new reports from The Business Research Company that provides telepharmacy market statistics, including telepharmacy industry global market size, regional shares, competitors with a telepharmacy market share, detailed telepharmacy market segments, market trends and opportunities, and any further data you may need to thrive in the telepharmacy industry. This telepharmacy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The telepharmacy market size has grown rapidly in recent years. It will grow from $12.23 $ billion in 2024 to $14.27 $ billion in 2025 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to the focus on reducing healthcare disparities, government, and health insurance initiatives, increased focus on preventive care, increased demand for remote healthcare services, and healthcare accessibility and rural outreach.

The telepharmacy market size is expected to see rapid growth in the next few years. It will grow to $26.18 $ billion in 2029 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increase in virtual care partnerships, growing adoption of cloud-based solutions, enhanced chronic disease management, demand for integrated care models, and growth of home healthcare services. Major trends in the forecast period include technological integration with wearable devices, development of mobile health (mHealth) applications, advancements in telecommunication technologies, advances in telehealth technologies, and integration with electronic health records (EHRs).

The rising demand for chronic disease management is expected to drive the growth of the telepharmacy market. Chronic disease management involves the continuous treatment, monitoring, and support of individuals with long-term medical conditions such as diabetes, hypertension, heart disease, asthma, and arthritis. This growing demand is due to the increasing prevalence of chronic conditions and the need for long-term, personalized care to enhance patient outcomes. Telepharmacy supports chronic disease management by offering remote medication counseling and monitoring, which improves patient adherence and access to care. For example, a report published by the American College of Cardiology in August 2022 projected that all four major cardiovascular risk factors in the United States would rise from 2025 to 2060. Diabetes is expected to see the largest increase, with a 39.3% rise to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). Thus, the growing need for chronic disease management is fueling the growth of the telepharmacy market.

Major players in the telepharmacy market are focusing on creating innovative solutions, such as telehealth platforms, to improve patient access to pharmaceutical care. A telehealth platform is a digital technology that enables the remote delivery of healthcare services using communication tools like video conferencing, messaging, and secure data sharing. This allows for virtual consultations, monitoring, diagnosis, and treatment between healthcare providers and patients without requiring in-person visits. For example, in January 2024, Eli Lilly, a U.S.-based pharmaceutical company, launched LillyDirect, a telehealth platform designed to sell certain medications directly to consumers. This innovative platform enables patients to obtain prescriptions for conditions such as obesity, migraines, and diabetes, bypassing traditional healthcare pathways and the usual doctor-to-pharmacy process. Key features include direct prescription access and home delivery.

In February 2023, Elevance Health, Inc., a U.S.-based health insurance provider, acquired BioPlus for an undisclosed amount. This acquisition will assist Elevance Health in addressing the specialty drug needs of its clients and customers with a comprehensive health approach, supported by programs across Elevance Health and Carelon, its healthcare services brand. BioPlus is a U.S.-based provider of telepharmacy services.

Major companies operating in the telepharmacy market are Cardinal Health Inc., Dartmouth-Hitchcock Medical Center, Comprehensive Pharmacy Services Inc., Tabula Rasa HealthCare, Alto Pharmacy, CarepathRx, Truepill, Carepoint Pharmacy, Pipeline Health Holdings, Nurx, Advanced Rx Management, Mosaic Wellness, MedTel Services, Medication Review Inc., Phlo, Locke Bio, PharmD Live, North West TelePharmacy Solutions, One Touch Telehealth, Heyva Health

North America was the largest region in the telepharmacy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the telepharmacy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the telepharmacy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The telepharmacy market consists of revenues earned by entities by providing services such as remote medication consultations, prescription management, and medication therapy reviews. The market value includes the value of related goods sold by the service provider or included within the service offering. The telepharmacy market also includes sales of bar code scanners, telemedicine carts, and automated dispensing machines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Telepharmacy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on telepharmacy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for telepharmacy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The telepharmacy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Inpatient; Remote Dispensing; Intravenous Admixture; Patient Counselling; Drug Therapy Monitoring; Refill Authorization For Prescription Drugs
  • 2) By Component: Hardware; Software
  • 3) By Delivery Mode: On Premises; Web Based; Cloud Based
  • 4) By Application: Hospitals; Small Pharmacies; Nursing Home; Prisons; Military Base; War Ships
  • Subsegments:
  • 1) Inpatient: Hospital Telepharmacy; Specialty Pharmacy
  • 2) Remote Dispensing: Automated Dispensing Machines; Remote Patient Monitoring
  • 3) Intravenous Admixture: Total Parenteral Nutrition; Compounded Medications
  • 4) Patient Counselling: Video Consultations; Chat Support
  • 5) Drug Therapy Monitoring: Adherence Monitoring; Side Effect Management
  • 6) Refill Authorization For Prescription Drugs: Automatic Refills; Patient Request Systems
  • Companies Mentioned: Cardinal Health Inc.; Dartmouth-Hitchcock Medical Center; Comprehensive Pharmacy Services Inc.; Tabula Rasa HealthCare; Alto Pharmacy
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Telepharmacy Market Characteristics

3. Telepharmacy Market Trends And Strategies

4. Telepharmacy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Telepharmacy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Telepharmacy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Telepharmacy Market Growth Rate Analysis
  • 5.4. Global Telepharmacy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Telepharmacy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Telepharmacy Total Addressable Market (TAM)

6. Telepharmacy Market Segmentation

  • 6.1. Global Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Inpatient
  • Remote Dispensing
  • Intravenous Admixture
  • Patient Counselling
  • Drug Therapy Monitoring
  • Refill Authorization For Prescription Drugs
  • 6.2. Global Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • 6.3. Global Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On Premises
  • Web Based
  • Cloud Based
  • 6.4. Global Telepharmacy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Small Pharmacies
  • Nursing Home
  • Prisons
  • Military Base
  • War Ships
  • 6.5. Global Telepharmacy Market, Sub-Segmentation Of Inpatient, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital Telepharmacy
  • Specialty Pharmacy
  • 6.6. Global Telepharmacy Market, Sub-Segmentation Of Remote Dispensing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automated Dispensing Machines
  • Remote Patient Monitoring
  • 6.7. Global Telepharmacy Market, Sub-Segmentation Of Intravenous Admixture, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Parenteral Nutrition
  • Compounded Medications
  • 6.8. Global Telepharmacy Market, Sub-Segmentation Of Patient Counselling, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Video Consultations
  • Chat Support
  • 6.9. Global Telepharmacy Market, Sub-Segmentation Of Drug Therapy Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adherence Monitoring
  • Side Effect Management
  • 6.10. Global Telepharmacy Market, Sub-Segmentation Of Refill Authorization For Prescription Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Automatic Refills
  • Patient Request Systems

7. Telepharmacy Market Regional And Country Analysis

  • 7.1. Global Telepharmacy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Telepharmacy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Telepharmacy Market

  • 8.1. Asia-Pacific Telepharmacy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Telepharmacy Market

  • 9.1. China Telepharmacy Market Overview
  • 9.2. China Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Telepharmacy Market

  • 10.1. India Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Telepharmacy Market

  • 11.1. Japan Telepharmacy Market Overview
  • 11.2. Japan Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Telepharmacy Market

  • 12.1. Australia Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Telepharmacy Market

  • 13.1. Indonesia Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Telepharmacy Market

  • 14.1. South Korea Telepharmacy Market Overview
  • 14.2. South Korea Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Telepharmacy Market

  • 15.1. Western Europe Telepharmacy Market Overview
  • 15.2. Western Europe Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Telepharmacy Market

  • 16.1. UK Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Telepharmacy Market

  • 17.1. Germany Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Telepharmacy Market

  • 18.1. France Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Telepharmacy Market

  • 19.1. Italy Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Telepharmacy Market

  • 20.1. Spain Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Telepharmacy Market

  • 21.1. Eastern Europe Telepharmacy Market Overview
  • 21.2. Eastern Europe Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Telepharmacy Market

  • 22.1. Russia Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Telepharmacy Market

  • 23.1. North America Telepharmacy Market Overview
  • 23.2. North America Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Telepharmacy Market

  • 24.1. USA Telepharmacy Market Overview
  • 24.2. USA Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Telepharmacy Market

  • 25.1. Canada Telepharmacy Market Overview
  • 25.2. Canada Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Telepharmacy Market

  • 26.1. South America Telepharmacy Market Overview
  • 26.2. South America Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Telepharmacy Market

  • 27.1. Brazil Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Telepharmacy Market

  • 28.1. Middle East Telepharmacy Market Overview
  • 28.2. Middle East Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Telepharmacy Market

  • 29.1. Africa Telepharmacy Market Overview
  • 29.2. Africa Telepharmacy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Telepharmacy Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Telepharmacy Market, Segmentation By Delivery Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Telepharmacy Market Competitive Landscape And Company Profiles

  • 30.1. Telepharmacy Market Competitive Landscape
  • 30.2. Telepharmacy Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Dartmouth-Hitchcock Medical Center Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Comprehensive Pharmacy Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Tabula Rasa HealthCare Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Alto Pharmacy Overview, Products and Services, Strategy and Financial Analysis

31. Telepharmacy Market Other Major And Innovative Companies

  • 31.1. CarepathRx
  • 31.2. Truepill
  • 31.3. Carepoint Pharmacy
  • 31.4. Pipeline Health Holdings
  • 31.5. Nurx
  • 31.6. Advanced Rx Management
  • 31.7. Mosaic Wellness
  • 31.8. MedTel Services
  • 31.9. Medication Review Inc.
  • 31.10. Phlo
  • 31.11. Locke Bio
  • 31.12. PharmD Live
  • 31.13. North West TelePharmacy Solutions
  • 31.14. One Touch Telehealth
  • 31.15. Heyva Health

32. Global Telepharmacy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Telepharmacy Market

34. Recent Developments In The Telepharmacy Market

35. Telepharmacy Market High Potential Countries, Segments and Strategies

  • 35.1 Telepharmacy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Telepharmacy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Telepharmacy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer